Free tool
Find any stock
Search all ~22,000 companies we cover across the US, Europe and Asia-Pacific, or browse them market by market — then open any one of them for the full analysis.
Search all ~22,000 companies we cover across the US, Europe and Asia-Pacific, or browse them market by market — then open any one of them for the full analysis.
Search all ~22,000 companies we cover across the US, Europe and Asia-Pacific, or browse them market by market — then open any one of them for the full analysis.
178 stocks in the Americas match these filters · market cap, largest first. Clear filters
Data as of Aug 27, 2026 · updates nightly, Mon–Sat
| Ticker | Company | Sector | Market cap (USD) | Price | vs 52-week high | 1M return |
|---|---|---|---|---|---|---|
| R1DY34.SA | Dr. Reddy's Laboratories Limited | Healthcare | $9.95B | 10.25 BRL | −21.76% | −15.29% |
| PODD | Insulet Corporation | Healthcare | $9.94B | $143.38 | −59.60% | −14.38% |
| AVTR | Avantor, Inc. | Healthcare | $9.81B | $14.50 | −8.98% | +16.75% |
| PTGX | Protagonist Therapeutics, Inc. | Healthcare | $9.80B | $151.50 | −5.79% |
Every company we cover sits in at least one of these lists. Each one opens as a full table of its members, ordered by market value.
The 11 business sectors every covered company is classified into.
The 20 narrower groupings we keep for parts of the market that do not split neatly by sector.
Price chart, technicals, money flow, fundamentals and an AI-written read — one page per stock, $9.90 each. Already know the symbol?
| +10.71% |
| NUVL | Nuvalent Inc | Healthcare | $9.79B | $123.96 | −0.02% | 0.00% |
| BIO-B | Bio-Rad Laboratories, Inc. | Healthcare | $9.77B | $365.08 | 0.00% | +18.01% |
| OSCR | Oscar Health, Inc. | Healthcare | $9.55B | $31.24 | −6.88% | −0.51% |
| TWST | Twist Bioscience Corporation | Healthcare | $9.41B | $150.06 | −3.16% | +69.46% |
| PCVX | Vaxcyte, Inc. | Healthcare | $9.09B | $61.09 | −6.02% | +11.89% |
| IMVT | Immunovant, Inc. | Healthcare | $9.07B | $43.89 | −3.37% | +12.83% |
| QGEN | Qiagen N.V. | Healthcare | $9.01B | $43.36 | −25.01% | +2.55% |
| CRNX | Crinetics Pharmaceuticals, Inc. | Healthcare | $9.00B | $84.84 | −0.05% | +1.17% |
| HQY | HealthEquity, Inc. | Healthcare | $8.75B | $104.42 | −2.97% | +3.14% |
| BRKR | Bruker Corporation | Healthcare | $8.69B | $57.06 | −12.62% | −9.30% |
| ATR | AptarGroup, Inc. | Healthcare | $8.60B | $135.24 | −7.94% | −1.52% |
| TGTX | TG Therapeutics, Inc. Common Stock | Healthcare | $8.42B | $55.03 | −7.20% | +0.29% |
| TXG | 10x Genomics, Inc. | Healthcare | $8.37B | $64.26 | −4.00% | +36.58% |
| ALKS | Alkermes plc | Healthcare | $8.25B | $49.16 | −11.69% | −2.65% |
| SYRE | Spyre Therapeutics, Inc. | Healthcare | $8.13B | $93.61 | −15.04% | −6.36% |
| RYTM | Rhythm Pharmaceuticals, Inc. | Healthcare | $7.78B | $111.87 | −8.45% | +3.54% |
| CAI | Caris Life Sciences, Inc. | Healthcare | $7.58B | $26.82 | −36.89% | +72.03% |
| SRRK | Scholar Rock Holding Corporation | Healthcare | $7.31B | $60.04 | −2.77% | +21.61% |
| HNGE | Hinge Health, Inc. | Healthcare | $7.25B | $90.50 | −3.21% | +20.27% |
| CHE | Chemed Corporation | Healthcare | $7.11B | $548.56 | −1.52% | +5.98% |
| PACS | PACS Group, Inc. | Healthcare | $7.03B | $44.39 | −10.31% | −5.47% |
| HIMS | Hims & Hers Health, Inc. | Healthcare | $6.96B | $29.83 | −54.32% | +1.74% |
| CGON | CG Oncology, Inc. | Healthcare | $6.95B | $78.42 | −3.15% | +7.99% |
| ERAS | Erasca, Inc. | Healthcare | $6.70B | $19.15 | −21.13% | +5.45% |
| E2XE34.SA | Exelixis, Inc. | Healthcare | $6.61B | 137.40 BRL | −2.25% | −2.25% |
| LNTH | Lantheus Holdings, Inc. | Healthcare | $6.58B | $100.82 | −9.87% | −1.77% |
| ORKA | Oruka Therapeutics, Inc. | Healthcare | $6.58B | $99.44 | −13.92% | +9.94% |
| RADL3.SA | Raia Drogasil S.A. | Healthcare | $6.56B | 19.31 BRL | −29.58% | +6.10% |
| COGT | Cogent Biosciences, Inc. | Healthcare | $6.39B | $36.72 | −16.03% | −9.71% |
| BLTE | Belite Bio, Inc | Healthcare | $6.31B | $156.69 | −21.66% | +0.47% |
| LQDA | Liquidia Corporation | Healthcare | $6.31B | $71.36 | −23.77% | −17.81% |
| CNTA | Centessa Pharmaceuticals plc | Healthcare | $6.27B | $40.50 | −0.15% | 0.00% |
| AMRX | Amneal Pharmaceuticals, Inc. | Healthcare | $6.27B | $17.99 | −6.59% | −4.10% |
| TVTX | Travere Therapeutics, Inc. | Healthcare | $6.24B | $67.12 | −0.56% | +20.05% |
| XENE | Xenon Pharmaceuticals Inc. | Healthcare | $6.18B | $63.79 | −12.21% | −1.77% |
| BLCO.TO | Bausch + Lomb Corporation | Healthcare | $6.18B | 24.00 CAD | −6.61% | +2.61% |
| BLCO | Bausch + Lomb Corporation | Healthcare | $6.16B | $17.25 | −8.80% | +3.85% |
| DNTH | Dianthus Therapeutics, Inc. | Healthcare | $6.13B | $110.76 | −6.04% | +9.01% |
| STVN | Stevanato Group S.p.A. | Healthcare | $6.11B | $22.38 | −20.07% | +11.07% |
| PTCT | PTC Therapeutics, Inc. Common Stock | Healthcare | $6.07B | $72.69 | −20.01% | −3.58% |
| KNSA | Kiniksa Pharmaceuticals International, plc | Healthcare | $6.05B | $78.68 | −5.14% | −0.96% |
| RDNT | RadNet, Inc. | Healthcare | $6.05B | $76.47 | −10.92% | +20.96% |
| T1FX34.SA | Teleflex Incorporated | Healthcare | $6.00B | 69.78 BRL | −6.95% | 0.00% |
| MIRM | Mirum Pharmaceuticals, Inc. | Healthcare | $5.98B | $98.51 | −24.22% | −12.22% |
| DFTX | Definium Therapeutics, Inc. | Healthcare | $5.88B | $43.77 | −11.93% | +4.31% |
| TFX | Teleflex Incorporated | Healthcare | $5.88B | $138.74 | −4.32% | +3.38% |
| LGND | Ligand Pharmaceuticals Incorporated | Healthcare | $5.74B | $287.85 | −11.87% | −2.85% |
| CRSP | CRISPR Therapeutics AG | Healthcare | $5.73B | $59.23 | −24.53% | +24.56% |
| SHC | Sotera Health Company | Healthcare | $5.58B | $19.54 | −1.56% | +10.02% |
| MMED | MiniMed Group, Inc. | Healthcare | $5.48B | $19.49 | −6.66% | +10.49% |
| MMSI | Merit Medical Systems, Inc. | Healthcare | $5.44B | $90.54 | −4.44% | +15.65% |
| GRFS | Grifols, S.A. | Healthcare | $5.38B | $7.90 | −22.78% | −1.25% |
| ACAD | ACADIA Pharmaceuticals Inc. | Healthcare | $5.07B | $29.58 | −4.46% | +13.73% |
| DYN | Dyne Therapeutics, Inc. | Healthcare | $4.92B | $26.36 | −3.46% | +1.78% |
| HAE | Haemonetics Corporation | Healthcare | $4.85B | $106.60 | −2.71% | +29.15% |
| EWTX | Edgewise Therapeutics, Inc. | Healthcare | $4.80B | $44.38 | −8.31% | +9.99% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.
Size bands, from the largest companies down to the smallest we cover.
The 23 listing venues our coverage spans, across the Americas, Europe and Asia-Pacific.
5 lists built on a single stated criterion, such as paying a dividend or trading near a 52-week high.
The largest one day percentage moves in either direction, among the mid, large and mega cap companies we cover.